AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 173 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (20-F)
- Quarterly reports (6-K)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $61,000 | -95.3% | 84,146 | -85.2% | 0.00% | – |
| Q4 2021 | $1,286,000 | +137.3% | 569,540 | +202.4% | 0.00% | – |
| Q3 2021 | $542,000 | -15.6% | 188,357 | +11.3% | 0.00% | – |
| Q2 2021 | $642,000 | -20.1% | 169,276 | -28.6% | 0.00% | – |
| Q1 2021 | $804,000 | +75.5% | 237,218 | +44.8% | 0.00% | – |
| Q4 2020 | $458,000 | -1.1% | 163,792 | -11.2% | 0.00% | – |
| Q3 2020 | $463,000 | -75.0% | 184,493 | +35.4% | 0.00% | -100.0% |
| Q2 2020 | $1,850,000 | +67.9% | 136,254 | -6.3% | 0.00% | 0.0% |
| Q1 2020 | $1,102,000 | +1.0% | 145,357 | -15.8% | 0.00% | 0.0% |
| Q4 2019 | $1,091,000 | +122.2% | 172,681 | +37.9% | 0.00% | – |
| Q3 2019 | $491,000 | -25.0% | 125,179 | -7.4% | 0.00% | – |
| Q2 2019 | $655,000 | -28.5% | 135,194 | +20.9% | 0.00% | -100.0% |
| Q1 2019 | $916,000 | +1507.0% | 111,782 | +993.3% | 0.00% | – |
| Q4 2018 | $57,000 | -93.2% | 10,224 | -89.2% | 0.00% | -100.0% |
| Q3 2018 | $839,000 | +466.9% | 95,045 | +542.0% | 0.00% | – |
| Q2 2018 | $148,000 | -50.0% | 14,805 | -52.5% | 0.00% | – |
| Q1 2018 | $296,000 | +10.4% | 31,145 | +73.2% | 0.00% | – |
| Q4 2017 | $268,000 | +793.3% | 17,984 | +1046.9% | 0.00% | – |
| Q3 2017 | $30,000 | -84.9% | 1,568 | -88.7% | 0.00% | – |
| Q2 2017 | $199,000 | +2111.1% | 13,898 | +1482.9% | 0.00% | – |
| Q1 2017 | $9,000 | -79.1% | 878 | -78.3% | 0.00% | – |
| Q4 2016 | $43,000 | +1333.3% | 4,052 | +1064.4% | 0.00% | – |
| Q3 2016 | $3,000 | -25.0% | 348 | -29.4% | 0.00% | – |
| Q2 2016 | $4,000 | +100.0% | 493 | +155.4% | 0.00% | – |
| Q1 2016 | $2,000 | -66.7% | 193 | -58.0% | 0.00% | – |
| Q4 2015 | $6,000 | -92.0% | 459 | -94.5% | 0.00% | – |
| Q3 2015 | $75,000 | +1150.0% | 8,377 | +1501.7% | 0.00% | – |
| Q2 2015 | $6,000 | +20.0% | 523 | +10.3% | 0.00% | – |
| Q1 2015 | $5,000 | +25.0% | 474 | +6.5% | 0.00% | – |
| Q4 2014 | $4,000 | +100.0% | 445 | +449.4% | 0.00% | – |
| Q3 2014 | $2,000 | -97.0% | 81 | -96.7% | 0.00% | – |
| Q2 2014 | $67,000 | – | 2,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |